Report cover image

Sickle Cell Disease Treatment Market

Publisher Coherent Market Insights
Published Jul 09, 2025
Length 140 Pages
SKU # CMI20303106

Description

The Global Sickle Cell Disease Treatment Market is estimated to be valued at USD 3.20 Bn in 2025 and is expected to reach USD 8.81 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 15.6% from 2025 to 2032. Sickle cell disease is a genetic blood disorder causing abnormal red blood cells. It affects the oxygen supply to tissues and organs in the body. This disorder is prevalent across worldwide, especially in Sub-Saharan Africa, the Middle East, Indian subcontinent, Mediterranean regions, and South and Central America. With growing diagnostic and detection rates, coupled with rising awareness regarding availability of advanced treatment options, the market is projected to showcase lucrative opportunities over the coming years. The development of new drug therapies and gene-therapy based treatment approaches are also fueling the market expansion.

Market Dynamics

Increasing research activities focusing on developing novel drugs and upcoming pipeline candidates are acting as a key growth driver for global sickle cell disease treatment market. Rising healthcare expenditures in emerging nations and favorable reimbursement policies are further supporting the market growth. Growing adoption of curative therapies such as bone marrow transplantation is also boosting the market. However, high costs associated with advanced treatment approaches and lack of awareness in underdeveloped regions are restraining the market growth. Rising adoption of gene-therapy based treatments presents significant opportunities for market players. Development of affordable regenerative treatment options also holds potential to create new avenues in the near future.

Key Features of the Study
  • This report provides in-depth analysis of the global sickle cell disease treatment market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global sickle cell disease treatment market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Novartis AG, Emmaus Medical Inc., Agios Pharmaceuticals Inc., Bluebird Bio, Pfizer Inc., Bristol-Myers Squibb Company, Celgene Corporation, GSK (GlaxoSmithKline), Sanofi S.A., Merck & Co., Inc., Amgen Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., Chugai Pharmaceutical Co., Ltd., and Daiichi Sankyo Company, Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global sickle cell disease treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sickle cell disease treatment market
Market Segmentation
  • By Treatment Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Blood Transfusion
  • Bone Marrow Transplant
  • Pharmacotherapy
  • Hydroxyurea Therapy
  • Oxbryta
  • Adakveo
  • Pain Management Drugs
  • Others
  • By Age Group Insights (Revenue, USD Bn, 2020 - 2032)
  • Adults
  • Pediatric
  • Geriatric
  • By Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
  • Oral
  • Parenteral
  • By End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospitals
  • Specialty Clinics
  • Homecare Settings
  • Others
  • By Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
  • Key Players Insights
  • Novartis AG
  • Emmaus Medical Inc.
  • Agios Pharmaceuticals Inc.
  • Bluebird Bio
  • Pfizer Inc.
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • GSK (GlaxoSmithKline)
  • Sanofi S.A.
  • Merck & Co., Inc.
  • Amgen Inc.
  • Bayer AG
  • Teva Pharmaceutical Industries Ltd.
  • Chugai Pharmaceutical Co., Ltd.
  • Daiichi Sankyo Company, Limited

Table of Contents

140 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Global Sickle Cell Disease Treatment Market, By Treatment Type
Global Sickle Cell Disease Treatment Market, By Age Group
Global Sickle Cell Disease Treatment Market, By Route of Administration
Global Sickle Cell Disease Treatment Market, By End User
Global Sickle Cell Disease Treatment Market, By Distribution Channel
Global Sickle Cell Disease Treatment Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
Industry Trends
4. Global Sickle Cell Disease Treatment Market, By Treatment Type, 2020-2032, (USD Billion)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Blood Transfusion
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Billion)
Bone Marrow Transplant
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Billion)
Pharmacotherapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Billion)
Hydroxyurea Therapy
Oxbryta
Adakveo
Pain Management Drugs
Others
5. Global Sickle Cell Disease Treatment Market, By Age Group, 2020-2032, (USD Billion)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Adults
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Billion)
Pediatric
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Billion)
Geriatric
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Billion)
6. Global Sickle Cell Disease Treatment Market, By Route of Administration, 2020-2032, (USD Billion)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Billion)
Parenteral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Billion)
7. Global Sickle Cell Disease Treatment Market, By End User, 2020-2032, (USD Billion)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Billion)
Specialty Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Billion)
Homecare Settings
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Billion)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Billion)
8. Global Sickle Cell Disease Treatment Market, By Distribution Channel, 2020-2032, (USD Billion)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Billion)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Billion)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Billion)
9. Global Sickle Cell Disease Treatment Market, By Region, 2020 - 2032, Value (USD Billion)
Introduction
Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Billion)
Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Billion)
Regional Trends
North America
Introduction
Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Billion)
Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Billion)
Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Billion)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Billion)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Billion)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Billion)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Billion)
Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Billion)
Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Billion)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Billion)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Billion)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Billion)
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Introduction
Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Billion)
Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Billion)
Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Billion)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Billion)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Billion)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Billion)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Billion)
Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Billion)
Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Billion)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Billion)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Billion)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Billion)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Billion)
Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Billion)
Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Billion)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Billion)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Billion)
Market Size and Forecast, By Country, 2020 - 2032, Value (USD Billion)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Billion)
Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Billion)
Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Billion)
Market Size and Forecast, By End User, 2020 - 2032, Value (USD Billion)
Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Billion)
Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Billion)
South Africa
North Africa
Central Africa
10. Competitive Landscape
Novartis AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Emmaus Medical Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Agios Pharmaceuticals Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Bluebird Bio
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Pfizer Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Bristol-Myers Squibb Company
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Celgene Corporation
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
GSK (GlaxoSmithKline)
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Sanofi S.A.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Merck & Co., Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Amgen Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Bayer AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Teva Pharmaceutical Industries Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Chugai Pharmaceutical Co., Ltd.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Daiichi Sankyo Company, Limited
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
11. Analyst Recommendations
Wheel of Fortune
Analyst View
Coherent Opportunity Map
12. References and Research Methodology
References
Research Methodology
About us
*Browse 60 market data tables and 40 figures on Sickle Cell Disease Treatment Market - Global forecast to 2032”

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us